FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1725848545> ?p ?o ?g. }

• W1725848545 endingPage "1400" @default.
• W1725848545 startingPage "1392" @default.
• W1725848545 abstract "Diabet. Med. 27, 1392–1400 (2010) Abstract Aims Cardiovascular mortality remains high despite intensive treatment of people with Type 2 diabetes mellitus. Meta‐analyses on rosiglitazone have raised concerns regarding its cardiovascular safety. We studied the effects of rosiglitazone on ultrasonic indices of carotid arterial disease and inflammatory markers in a group of Type 2 diabetic patients at high cardiovascular risk. Methods A trial of rosiglitazone in Type 2 diabetic patients with high cardiovascular risk and internal carotid artery plaque compared changes in carotid ultrasound intima–media thickness (IMT), plaque thickness, arterial stiffness and compliance, and inflammatory markers at baseline, 26 and 52 weeks. Results In the rosiglitazone group ( n = 28), carotid artery plaque thickness was reduced by 0.08 mm, compared with an increase of 0.19 mm ( P = 0.075) in the placebo group ( n = 29). There were no significant differences in changes of IMT, carotid wall compliance and stiffness between the two groups. Glycated haemoglobin reduced by −0.9 vs. 0.1% (−7 vs. 2 mmol/mol), ( P < 0.001); insulin resistance (HOMA‐IR) reduced by −37.6 vs. −1.1% ( P = 0.016); and B cell function (HOMA‐B) increased by 36.8 vs. 0.7% ( P = 0.009). Non‐esterified fatty acids reduced by −23.5 vs. 7.9% ( P = 0.005); tissue plasminogen activator reduced by −25.0 vs. 0.6% ( P = 0.001); and plasminogen activator inhibitor activity reduced by −57.4 vs. −34.6% ( P = 0.052). Conclusions Rosiglitazone reduced carotid artery plaque thickness, though not significantly, and there was no significant change in intima media thickness or other ultrasonic indices of carotid arterial disease. There were significant improvements in glycaemic control, insulin sensitivity and fibrinolytic, but not inflammatory, markers. There was no evidence in this study of any adverse effects on progression of carotid arterial disease." @default.
• W1725848545 created "2016-06-24" @default.
• W1725848545 creator A5016750546 @default.
• W1725848545 creator A5024937865 @default.
• W1725848545 creator A5044842316 @default.
• W1725848545 creator A5052841660 @default.
• W1725848545 creator A5056480314 @default.
• W1725848545 creator A5089397114 @default.
• W1725848545 date "2010-11-09" @default.
• W1725848545 modified "2023-10-17" @default.
• W1725848545 title "The effects of rosiglitazone on atherosclerotic progression in patients with Type 2 diabetes at high cardiovascular risk" @default.
• W1725848545 cites W1965408926 @default.
• W1725848545 cites W1968973887 @default.
• W1725848545 cites W1978021168 @default.
• W1725848545 cites W1987941106 @default.
• W1725848545 cites W2001772900 @default.
• W1725848545 cites W2005761359 @default.
• W1725848545 cites W2007453649 @default.
• W1725848545 cites W2016183600 @default.
• W1725848545 cites W2024765976 @default.
• W1725848545 cites W2025973118 @default.
• W1725848545 cites W2050695519 @default.
• W1725848545 cites W2057492075 @default.
• W1725848545 cites W2058599631 @default.
• W1725848545 cites W2064617441 @default.
• W1725848545 cites W2067911881 @default.
• W1725848545 cites W2069874075 @default.
• W1725848545 cites W2092881968 @default.
• W1725848545 cites W2094394439 @default.
• W1725848545 cites W2100474997 @default.
• W1725848545 cites W2102469433 @default.
• W1725848545 cites W2105407506 @default.
• W1725848545 cites W2116544253 @default.
• W1725848545 cites W2127125241 @default.
• W1725848545 cites W2134293572 @default.
• W1725848545 cites W2140853784 @default.
• W1725848545 cites W2159969745 @default.
• W1725848545 cites W2164367541 @default.
• W1725848545 cites W2170286857 @default.
• W1725848545 cites W2337454357 @default.
• W1725848545 cites W4238909759 @default.
• W1725848545 doi "https://doi.org/10.1111/j.1464-5491.2010.03089.x" @default.
• W1725848545 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21059092" @default.
• W1725848545 hasPublicationYear "2010" @default.
• W1725848545 type Work @default.
• W1725848545 sameAs 1725848545 @default.
• W1725848545 citedByCount "10" @default.
• W1725848545 countsByYear W17258485452012 @default.
• W1725848545 countsByYear W17258485452013 @default.
• W1725848545 countsByYear W17258485452014 @default.
• W1725848545 countsByYear W17258485452020 @default.
• W1725848545 countsByYear W17258485452021 @default.
• W1725848545 crossrefType "journal-article" @default.
• W1725848545 hasAuthorship W1725848545A5016750546 @default.
• W1725848545 hasAuthorship W1725848545A5024937865 @default.
• W1725848545 hasAuthorship W1725848545A5044842316 @default.
• W1725848545 hasAuthorship W1725848545A5052841660 @default.
• W1725848545 hasAuthorship W1725848545A5056480314 @default.
• W1725848545 hasAuthorship W1725848545A5089397114 @default.
• W1725848545 hasConcept C126322002 @default.
• W1725848545 hasConcept C134018914 @default.
• W1725848545 hasConcept C142724271 @default.
• W1725848545 hasConcept C164705383 @default.
• W1725848545 hasConcept C204787440 @default.
• W1725848545 hasConcept C27081682 @default.
• W1725848545 hasConcept C2775850156 @default.
• W1725848545 hasConcept C2777180221 @default.
• W1725848545 hasConcept C2777391703 @default.
• W1725848545 hasConcept C2779306644 @default.
• W1725848545 hasConcept C2779679481 @default.
• W1725848545 hasConcept C2780152017 @default.
• W1725848545 hasConcept C2910068830 @default.
• W1725848545 hasConcept C555293320 @default.
• W1725848545 hasConcept C71924100 @default.
• W1725848545 hasConcept C84393581 @default.
• W1725848545 hasConceptScore W1725848545C126322002 @default.
• W1725848545 hasConceptScore W1725848545C134018914 @default.
• W1725848545 hasConceptScore W1725848545C142724271 @default.
• W1725848545 hasConceptScore W1725848545C164705383 @default.
• W1725848545 hasConceptScore W1725848545C204787440 @default.
• W1725848545 hasConceptScore W1725848545C27081682 @default.
• W1725848545 hasConceptScore W1725848545C2775850156 @default.
• W1725848545 hasConceptScore W1725848545C2777180221 @default.
• W1725848545 hasConceptScore W1725848545C2777391703 @default.
• W1725848545 hasConceptScore W1725848545C2779306644 @default.
• W1725848545 hasConceptScore W1725848545C2779679481 @default.
• W1725848545 hasConceptScore W1725848545C2780152017 @default.
• W1725848545 hasConceptScore W1725848545C2910068830 @default.
• W1725848545 hasConceptScore W1725848545C555293320 @default.
• W1725848545 hasConceptScore W1725848545C71924100 @default.
• W1725848545 hasConceptScore W1725848545C84393581 @default.
• W1725848545 hasIssue "12" @default.
• W1725848545 hasLocation W17258485451 @default.
• W1725848545 hasLocation W17258485452 @default.
• W1725848545 hasOpenAccess W1725848545 @default.
• W1725848545 hasPrimaryLocation W17258485451 @default.
• W1725848545 hasRelatedWork W2037868476 @default.
• W1725848545 hasRelatedWork W2364632151 @default.

• next